Suppr超能文献

c-Kit和血小板衍生生长因子受体α(PDGFRα)在上皮性卵巢肿瘤及肿瘤间质中的表达。

Expression of c-Kit and PDGFRα in epithelial ovarian tumors and tumor stroma.

作者信息

Yi Cunjian, Li Li, Chen Keming, Lin Shengrong, Liu Xiangqiong

机构信息

Department of Obstetrics and Gynecology, First Affiliated Hospital, Yangtze University, Jingzhou, Hubei 434000, P.R. China.

出版信息

Oncol Lett. 2012 Feb;3(2):369-372. doi: 10.3892/ol.2011.481. Epub 2011 Nov 15.

Abstract

The purpose of this study was to investigate the expression of c-Kit and platelet-derived growth factor receptor α (PDGFRα) in epithelial ovarian tumor cells and tumor stroma. The expression of c-Kit and PDGFRα in 71 malignant or benign epithelial ovarian tumor tissues and 20 normal ovarian tissues was evaluated by immunohistochemical staining. The expression of c-Kit and PDGFRα in 71 malignant epithelial ovarian tumors and tumor stroma tissue samples was analyzed. A significant increase (P<0.01) of c-Kit expression was observed in malignant ovarian tumors (50.7%) when compared to normal ovarian tissues (10.0%) or benign ovarian tumors (20.0%). The PDGFRα expression rate in malignant ovarian tumors (63.4%) was also significantly higher (P<0.01) than that in normal ovarian tissues (15.0%) or benign ovarian tumors (25.0%). c-Kit was expressed in only 4.2% of the tumor stroma samples, which was significantly lower than the expression of malignant ovarian tumors (P<0.01), whereas the PDGFRα expression in tumor stroma (87.3%) was significantly higher than that of the malignant ovarian tumors (P<0.01). The expression levels of c-Kit and PDGFRα are higher in the malignant ovarian tumors than in the benign ovarian tumors or normal tissues. In the malignant ovarian tumor stroma, c-Kit expression is low and PDGFRα expression is high, and the differential changes of c-kit and PDGFRα suggest distinct roles in ovarian cancer.

摘要

本研究的目的是调查c-Kit和血小板衍生生长因子受体α(PDGFRα)在上皮性卵巢肿瘤细胞和肿瘤基质中的表达情况。采用免疫组织化学染色法评估71例恶性或良性上皮性卵巢肿瘤组织及20例正常卵巢组织中c-Kit和PDGFRα的表达。分析71例恶性上皮性卵巢肿瘤及肿瘤基质组织样本中c-Kit和PDGFRα的表达。与正常卵巢组织(10.0%)或良性卵巢肿瘤(20.0%)相比,恶性卵巢肿瘤中c-Kit表达显著增加(P<0.01)(50.7%)。恶性卵巢肿瘤中PDGFRα表达率(63.4%)也显著高于正常卵巢组织(15.0%)或良性卵巢肿瘤(25.0%)(P<0.01)。c-Kit仅在4.2%的肿瘤基质样本中表达,显著低于恶性卵巢肿瘤的表达(P<0.01),而肿瘤基质中PDGFRα表达(87.3%)显著高于恶性卵巢肿瘤(P<0.01)。恶性卵巢肿瘤中c-Kit和PDGFRα的表达水平高于良性卵巢肿瘤或正常组织。在恶性卵巢肿瘤基质中,c-Kit表达低而PDGFRα表达高,c-kit和PDGFRα的差异变化提示它们在卵巢癌中发挥不同作用。

相似文献

9
Lack of expression of c-KIT in ovarian cancers is associated with poor prognosis.
Int J Cancer. 2000 May 20;89(3):242-50. doi: 10.1002/1097-0215(20000520)89:3<242::aid-ijc6>3.0.co;2-6.

本文引用的文献

9
KIT in ovarian carcinoma: disillusion about a potential therapeutic target.
J Natl Cancer Inst. 2003 Jul 2;95(13):1009-10. doi: 10.1093/jnci/95.13.1009-a.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验